| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |